The effect of imatinib mesylate on pro-angiogenic cytokines in patients with relapsed epithelial ovarian cancer (EOC)

被引：0
|
作者：
不详
机构：
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2004年 / 21卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [1] A phase II clinical trial with proteomic profiling of imatinib mesylate in patients with refractory or relapsed epithelial ovarian cancer (EOC).
    Posadas, EM
    Hussain, MM
    Espina, V
    Kotz, H
    Minasian, L
    Shreeve, SM
    Premkumar, A
    Liotta, LA
    Steinberg, SM
    Kohn, EC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 872S - 872S
  • [2] Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
    K Miyahara
    K Nouso
    Y Morimoto
    Y Takeuchi
    H Hagihara
    K Kuwaki
    H Onishi
    F Ikeda
    Y Miyake
    S Nakamura
    H Shiraha
    A Takaki
    M Honda
    S Kaneko
    T Sato
    S Sato
    S Obi
    S Iwadou
    Y Kobayashi
    K Takaguchi
    K Kariyama
    Y Takuma
    H Takabatake
    K Yamamoto
    [J]. British Journal of Cancer, 2013, 109 : 2072 - 2078
  • [3] Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
    Miyahara, K.
    Nouso, K.
    Morimoto, Y.
    Takeuchi, Y.
    Hagihara, H.
    Kuwaki, K.
    Onishi, H.
    Ikeda, F.
    Miyake, Y.
    Nakamura, S.
    Shiraha, H.
    Takaki, A.
    Honda, M.
    Kaneko, S.
    Sato, T.
    Sato, S.
    Obi, S.
    Iwadou, S.
    Kobayashi, Y.
    Takaguchi, K.
    Kariyama, K.
    Takuma, Y.
    Takabatake, H.
    Yamamoto, K.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2072 - 2078
  • [4] Monotherapy with gemcitabine in elderly patients with relapsed or persistent epithelial ovarian cancer (eoc) platinum resistant
    Aml, Capobianco
    Ardito, R.
    Am, Bochicchio
    Coccaro, M.
    Di, Leo P.
    Romano, C.
    Tartarone, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
  • [5] Monotherapy with gemcitabine in elderly patients with relapsed or persistent epithelial ovarian cancer (EOC) platinum resistant
    Capobianco, A. M. L.
    Ardito, R.
    Bochicchio, A. M.
    Coccaro, M.
    Di, Leo P.
    Romano, C.
    Tartarone, A.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
  • [6] Regulation of pro-angiogenic and pro-inflammatory cytokines in tumor cells: Implication of epithelial-to-mesenchymal transitions
    Suarez-Carmona, Meggy
    Bourcy, Morgane
    Foidart, Jean-Michel
    Delvenne, Philippe
    Noel, Agnes
    Polette, Myriam
    Gilles, Christine
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [7] Understanding the Function of a Pro-Angiogenic Polypeptide hFGF-1 with a Cancer Inhibitor Imatinib
    Modi, Tulsi
    Filani, Oluwadamilola
    Payne, Jason
    Murthy, Raja
    [J]. BIOPHYSICAL JOURNAL, 2015, 108 (02) : 54A - 55A
  • [8] Metformin prevents NGF-dependent proliferative and pro-angiogenic effects in epithelial ovarian cancer and endothelial cells
    Garrido, Maritza
    Vega, Margarita
    Quest, Andrew
    Romero, Carmen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S16 - S16
  • [9] A cross-sectional study: The correlation of pro-angiogenic factors expression level and epithelial ovarian cancer staging
    Prakosa, Teguh
    Mudigdo, Ambar
    Purwanto, Bambang
    Wasita, Brian
    Cilmiaty, Risya
    Widianingsih, Vitri
    [J]. BALI MEDICAL JOURNAL, 2020, 9 (01) : 125 - 128
  • [10] Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)
    Kolomainen, D. F.
    Daponte, A.
    Barton, D. P. J.
    Pennert, K.
    Ind, T. E. J.
    Bridges, J. E.
    Shepherd, J. H.
    Gore, M. E.
    Kaye, S. B.
    Riley, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 31 - 36
12345